The CRRSP55 Antibody is a monoclonal antibody designed to target specific proteins in Arabidopsis thaliana (mouse-ear cress), a model organism widely used in plant biology research. Limited data from commercial catalogs indicate it is available in two formats: 2 mL and 0.1 mL vials, likely standardized for immunological assays .
| Property | Details |
|---|---|
| Product Code | CSB-PA885454XA01DOA |
| Target Organism | Arabidopsis thaliana |
| Size Available | 2 mL / 0.1 mL |
| Supplier | Cusabio (a biotechnology company specializing in antibodies and proteins) |
While no peer-reviewed studies explicitly detail the use of CRRSP55 Antibody, its design suggests applications in:
Protein localization: Identifying subcellular distribution of target proteins in Arabidopsis.
Interaction studies: Detecting binding partners via co-immunoprecipitation (Co-IP) or Western blotting.
Functional analysis: Investigating roles in plant stress responses, growth regulation, or metabolic pathways.
A comprehensive review of publicly available literature (including PubMed, PMC, and preprint repositories) reveals no direct studies on CRRSP55 Antibody. This absence may reflect:
Early-stage development: The antibody could be newly synthesized or under experimental validation.
Niche focus: Its utility might be confined to specialized plant biology research, limiting broader publication.
To validate CRRSP55 Antibody’s efficacy, researchers should:
Perform specificity testing: Use Western blotting or immunohistochemistry to confirm target recognition.
Optimize protocols: Determine ideal dilutions and blocking conditions for Arabidopsis tissue samples.
Cross-reference with orthologs: Explore homology to proteins in other plant species to broaden utility.
CRRSP55 is a protein encoded by the Q9LV60 gene in Arabidopsis thaliana (Mouse-ear cress), a model organism widely used in plant molecular biology. While the detailed function of CRRSP55 remains an active area of investigation, polyclonal antibodies against this protein serve as important tools for studying its expression, localization, and interactions within plant cellular systems. The antibody enables researchers to detect and quantify CRRSP55 protein in various experimental contexts, contributing to our understanding of plant cellular processes .
CRRSP55 Antibody has been validated for enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) applications. These techniques allow researchers to detect and quantify CRRSP55 protein in experimental samples. ELISA provides quantitative measurement of CRRSP55 in solution, while Western blotting enables detection of the protein in cell or tissue lysates with information about molecular weight and relative abundance .
The CRRSP55 Antibody should be stored at -20°C or -80°C upon receipt. Researchers should avoid repeated freeze-thaw cycles as this can degrade antibody performance. The antibody is supplied in liquid form in a storage buffer containing 0.03% Proclin 300 as a preservative, 50% Glycerol, and 0.01M PBS at pH 7.4. This formulation helps maintain antibody stability during long-term storage. When planning experiments, it's advisable to aliquot the antibody into smaller volumes to minimize freeze-thaw cycles .
Validating antibody specificity is crucial for research integrity. For CRRSP55 Antibody, a comprehensive validation approach should include:
Positive and negative controls: Use wild-type Arabidopsis thaliana samples as positive controls and CRRSP55 knockout lines as negative controls.
Peptide competition assay: Pre-incubate the antibody with excess purified recombinant CRRSP55 protein (the immunogen) before application to your samples. Specific binding should be significantly reduced.
Cross-reactivity testing: Test the antibody against samples from related plant species to assess potential cross-reactivity.
Multiple detection methods: Confirm findings using both ELISA and Western blot to ensure consistent results across different platforms.
This approach mirrors established validation protocols similar to those used for other research antibodies such as those described for PD-1 antibodies, where multiple detection methods help establish specificity .
When preparing Arabidopsis thaliana samples for CRRSP55 detection:
Tissue selection: Choose appropriate tissues based on known or expected expression patterns of CRRSP55.
Extraction buffer optimization: Use a buffer containing:
50 mM Tris-HCl (pH 7.5)
150 mM NaCl
1% Triton X-100
0.5% sodium deoxycholate
Protease inhibitor cocktail
Mechanical disruption: For plant tissues, use methods similar to those described in antibody research involving tissue disruption: "dissection of tissue into small fragments followed by digestion at room temperature in a bacterial shaker at 180 rpm for 30 minutes" .
Protein quantification: Use Bradford or BCA assay to ensure equal loading of samples.
Sample denaturation: Heat samples at 95°C for 5 minutes in reducing sample buffer before Western blot analysis.
Co-immunoprecipitation (Co-IP) using CRRSP55 Antibody can identify potential protein interaction partners through the following methodology:
Antibody immobilization: Conjugate the CRRSP55 Antibody to protein A/G beads or use commercial antibody conjugation kits.
Lysate preparation: Prepare plant lysates under non-denaturing conditions to preserve protein-protein interactions.
Pre-clearing: Incubate lysates with protein A/G beads alone to remove non-specific binding proteins.
Immunoprecipitation: Incubate pre-cleared lysates with immobilized CRRSP55 Antibody.
Elution and analysis: Elute bound proteins and analyze by mass spectrometry or Western blot.
Validation: Confirm interactions using reverse Co-IP and orthogonal methods.
This approach parallels established immunoprecipitation protocols used in antibody research, as referenced in methodological descriptions where antibodies were used for immunoprecipitation (IP) applications .
When designing comparative studies examining CRRSP55 expression under different stress conditions:
Experimental controls: Include technical replicates, biological replicates, and time-matched controls for each stress condition.
Normalization strategy: Use multiple reference proteins (not just one housekeeping gene) for normalization.
Quantification method: Implement densitometry analysis for Western blots with appropriate software.
Statistical analysis: Apply appropriate statistical tests for comparing multiple conditions.
Time-course considerations: Design experiments to capture both acute and chronic responses to stress.
Cross-validation: Confirm protein-level changes with transcript-level analysis (RT-qPCR).
This approach ensures robust data collection similar to comparative analyses described in antibody research methodologies, where careful experimental design enables meaningful comparisons .
| Challenge | Possible Causes | Solutions |
|---|---|---|
| No signal | Low CRRSP55 expression, Improper antibody dilution, Insufficient antigen | Increase protein load (50-100 μg), Optimize antibody concentration (try 1:500 to 1:2000 dilutions), Use more sensitive detection methods |
| High background | Non-specific binding, Insufficient blocking, Inadequate washing | Increase blocking time/concentration, Optimize antibody dilution, Add 0.05-0.1% Tween-20 to wash buffer, Increase wash steps duration and number |
| Multiple bands | Cross-reactivity, Protein degradation, Post-translational modifications | Verify with knockout controls, Add protease inhibitors, Analyze bands by mass spectrometry |
| Inconsistent results | Variable sample preparation, Antibody degradation, Transfer issues | Standardize protocols, Use fresh aliquots of antibody, Optimize transfer conditions |
This troubleshooting table incorporates principles similar to those used when optimizing other research antibodies in experimental workflows .
Optimizing ELISA protocols for CRRSP55 detection requires:
Antibody titration: Test multiple dilutions (1:500, 1:1000, 1:2000, 1:5000) to determine optimal signal-to-noise ratio.
Coating buffer optimization: Compare carbonate buffer (pH 9.6) versus PBS (pH 7.4) for antigen or capture antibody coating.
Blocking optimization: Test different blocking agents (BSA, milk powder, commercial blockers) at various concentrations (1-5%).
Sample preparation: Optimize extraction buffers and determine if sample dilution series is needed.
Incubation parameters: Test different temperatures (4°C, room temperature, 37°C) and timing (1-16 hours).
Detection system selection: Choose between colorimetric, fluorescent, or chemiluminescent detection based on sensitivity requirements.
This methodological approach draws on established ELISA optimization principles applicable to various research antibodies .
CRRSP55 Antibody can be integrated into plant biology research through:
Developmental profiling: Track CRRSP55 expression across different developmental stages and tissues using immunohistochemistry and Western blotting.
Stress response studies: Analyze CRRSP55 regulation under various biotic and abiotic stresses using quantitative Western blotting.
Subcellular localization: Combine immunofluorescence microscopy with cellular fractionation to determine CRRSP55 localization and potential translocation during stress responses.
Protein modification analysis: Use immunoprecipitation followed by mass spectrometry to identify post-translational modifications of CRRSP55 during developmental transitions or stress responses.
Genetic interaction studies: Compare CRRSP55 expression and localization in various Arabidopsis mutant backgrounds to position it within known signaling pathways.
This multipronged research approach draws on methodological principles used in complex antibody-based research studies .
For successful immunohistochemistry with CRRSP55 Antibody:
Fixation optimization: Test multiple fixatives (4% paraformaldehyde, glutaraldehyde, or combinations) and fixation times.
Antigen retrieval methods: Compare heat-induced epitope retrieval methods (citrate buffer pH 6.0 vs. EDTA buffer pH 9.0) and enzymatic retrieval approaches.
Antibody dilution: Determine optimal dilution through systematic titration (typically starting at 1:100-1:500).
Detection system: Choose between fluorescent secondary antibodies for co-localization studies or enzymatic detection (HRP/DAB) for brightfield analysis.
Controls: Include positive control tissues, negative controls (primary antibody omission), and where possible, CRRSP55 knockout tissues.
Counterstaining: Select appropriate counterstains based on detection method and research question.
These methodological considerations reflect established practices in immunohistochemistry using research antibodies for protein localization studies .
Adapting CRRSP55 Antibody for high-throughput screening could involve:
Microarray adaptation: Develop protein microarrays using CRRSP55 Antibody for screening plant extracts or chemical libraries.
Automated ELISA platforms: Optimize protocols for robotic liquid handling systems to enable screening of large sample sets.
Bead-based multiplex assays: Conjugate CRRSP55 Antibody to spectrally distinct beads for multiplexed detection alongside other targets.
High-content imaging: Develop immunofluorescence protocols compatible with automated microscopy and image analysis pipelines.
Flow cytometry applications: Adapt protocols for single-cell analysis of plant protoplasts using fluorescently labeled CRRSP55 Antibody.
These approaches draw on high-throughput methodologies developed for other research antibodies, adapting established principles to plant biology applications .